Skip to main content Accessibility help
×
Home
  • Get access
    Check if you have access via personal or institutional login
  • Cited by 1
  • Print publication year: 2013
  • Online publication date: May 2013

11 - Pediatric depression

from Section 2 - Medical management

Summary

Chronic depression and dysthymia are even more likely to co-exist with anxiety disorders; indeed, some authors argue that dysthymic disorder (DD) is less common in a pure form than in a mixed depression, anxiety co-morbidity, for which the term cothymia has been proposed. Attention deficit hyperactivity disorder (ADHD) is an under-recognized problem in adults and is a common complicating factor in depression. People with depression have more Axis II disorders (most commonly dependent, avoidant, histrionic, or borderline personality disorder) than the general population. Individuals with chronic depression have more co-morbid Axis II disorders than do individuals with episodic major depression. Chronic depression, regardless of severity level, is associated with considerable functional impairment and morbidity. Chronic low-grade depression causes significant impairment and suffering. Dysthymia can be conceptualized as a prodromal disorder, since nearly all individuals with DD will at some point experience a full-blown major depressive episode.

References

Anderson, H.D., Pace, W.D., Libby, A.M., West, D.R., and Valuck, R.J. (2012). Rates of 5 common antidepressant side effects among new adult and adolescent cases of depression: A retrospective US claims study. Clinical Therapeutics, 34, 113–123.
Angold, A. and Costello, E.J. (2006). Puberty and depression. Child and Adolescent Psychiatric Clinics of North America, 15, 919–937.
Asarnow, J.R., Emslie, G., Clarke, G.et al. (2009). Treatment of selective serotonin reuptake inhibitor-resistant depression in adolescents: Predictors and moderators of treatment response. Journal of the American Academy of Child and Adolescent Psychiatry, 48, 330–339.
Asarnow, J.R., Porta, G., Emslie, G.et al. (2011). Suicide attempts and nonsuicidal self-injury in the Treatment of Resistant-Depression in Adolescents (TORDIA) study: Findings from the TORDIA trial. Journal of the American Academy of Child and Adolescent Psychiatry, 50, 772–781.
Atomoxetine ADHD and Comorbid MDD Study Group, Bangs, M.E., Emslie, G.J.et al. (2007). Efficacy and safety of atomoxetine in adolescents with attention-deficit/hyperactivity disorder and major depression. Journal of Child and Adolescent Psychopharmacology, 17, 407–420.
Bandelow, B. (2008). The medical treatment of obsessive-compulsive disorder and anxiety. CNS Spectrums, 13, 37–46.
Bendz, L.M. and Scates, A.C. (2010). Melatonin treatment for insomnia in pediatric patients with attention-deficit/ hyperactivity disorder. Annals of Pharmacotherapy, 44, 185–191.
Biederman, J., Spencer, T., and Wilens, T. (2004). Evidence-based pharmacotherapy for attention-deficit hyperactivity disorder. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (CINP), 7, 77–97.
Biederman, J., Joshi, G., Mick, E.et al. (2010). A prospective open-label trial of lamotrigine monotherapy in children and adolescents with bipolar disorder. CNS Neuroscience and Therapeutics, 16, 91–102.
Birmaher, B., Arbelaez, C., and Brent, D. (2002). Course and outcome of child and adolescent major depressive disorder. Child and Adolescent Psychiatric Clinics of North America, 11, 619–637.
Birmaher, B., Brent, D., AACAP Work Group on Quality Issues et al. (2007). Practice parameters for the assessment and treatment of children and adolescents with depressive disorders. Journal of the American Academy of Child and Adolescent Psychiatry, 46, 1503–1526.
Bloch, Y., Sobol, D., Levkovitz, Y., Kron, S., and Ratzoni, G. (2008). Reasons for referral for electroconvulsive therapy: A comparison between adolescents and adults. Australasian Psychiatry, 16, 191–194.
Bond, D.J., Hadjipavlou, G., Lam, R.W.et al. (2012). The Canadian Network for Mood and Anxiety Treatments (CANMAT) task force recommendations for the management of patients with mood disorders and comorbid attention-deficit/hyperactivity disorder. Annals of Clinical Psychiatry, 24, 23–37.
Brent, D., Emslie, G., Clarke, G.et al. (2008). Switching to another SSRI or to venlafaxine with or without cognitive behavioral therapy for adolescents with SSRI-resistant depression: The TORDIA randomized controlled trial. Journal of the American Medical Association, 299, 901–913.
Brent, D., Emslie, G., Clarke, G.et al. (2009). Predictors of spontaneous and systematically assessed suicidal adverse events in the treatment of SSRI-resistant depression in adolescents (TORDIA) study. American Journal of Psychiatry, 166, 418–426.
Brent, D.A., Holder, D., Kolko, D.et al. (1997). A clinical psychotherapy trial for adolescent depression comparing cognitive, family, and supportive treatments. Archives of General Psychiatry, 54, 877–885.
Brent, D.A., Kolko, D., Birmaher, B.et al. (1998). Predictors of treatment efficacy in a clinical trial of three psychosocial treatments for adolescent depression. Journal of the American Academy of Child and Adolescent Psychiatry, 37, 906–914.
Bridge, J., Iyengar, S., Salary, C.B.et al. (2007). Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric antidepressant treatment: A meta-analysis of randomized controlled trials. Journal of the American Medical Association, 297, 1683–1696.
Bridge, J.A., Goldstein, T.R., and Brent, D.A. (2006). Adolescent suicide and suicidal behavior. Journal of Child Psychology and Psychiatry, 47, 372–394.
Bridge, J.A., Birmaher, B., Iyengar, S., Barbe, R.P., and Brent, D.A. (2009). Placebo response in randomized controlled trials of antidepressants for pediatric major depressive disorder. American Journal of Psychiatry, 166, 42–49.
Chang, K., Saxena, K., and Howe, M. (2006). An open-label study of lamotrigine adjunct or monotherapy for the treatment of adolescents with bipolar depression. Journal of the American Academy of Child and Adolescent Psychiatry, 45, 298–304.
Cornelius, J.R., Bukstein, O.G., Wood, D.S.et al. (2009). Double-blind placebo-controlled trial of fluoxetine in adolescents with comorbid major depression and an alcohol use disorder. Addictive Behaviors, 34, 905–909.
Cornelius, J.R., Bukstein, O.G., Douaihy, A.B.et al. (2010). Double-blind fluoxetine trial in comorbid MDD-CUD youth and young adults. Drug and Alcohol Dependence, 112, 39–45.
Curry, J., Rohde, P., Simons, S.et al. (2006). Predictors and moderators of acute outcome in the Treatment for Adolescents with Depression Study (TADS). Journal of the American Academy of Child and Adolescent Psychiatry, 45, 1427–1439.
Curry, J., Silva, S., Rohde, P.et al. (2012). Onset of alcohol or substance use disorders following treatment for adolescent depression.Journal of Consulting and Clinical Psychology, 80, 299–312.
Dahl, R. (2011). Understanding the risky business of adolescence. Neuron, 69, 837–839.
Davey, C.G., Yucel, M., and Allen, N.B. (2008). The emergence of depression in adolescence: Development of the prefrontal cortex and the representation of reward. Neuroscience and Biobehavioral Reviews, 32, 1–19.
Daviss, W.B., Perel, J.M., Brent, D.A.et al. (2006). Acute antidepressant response and plasma levels of bupropion and metabolites in a pediatric-aged sample: an exploratory study. Therapeutic Drug Monitoring, 28, 190–198.
Diamond, G.S., Reis, B.F., Diamond, G.M., Siqueland, L., and Isaacs, L. (2002). Attachment-based family therapy for depressed adolescents: A treatment development study. Journal of the American Academy of Child and Adolescent Psychiatry, 41, 1190–1196.
Diamond, G.S., Wintersteen, M.B., Brown, G.K.et al. (2010). Attachment-based family therapy for adolescents with suicidal ideation: A randomized controlled trial. Journal of the American Academy of Child and Adolescent Psychiatry, 49, 122–131.
Dietz, L.J., Mufson, L., Irvine, H., and Brent, D.A. (2008). Family-based interpersonal psychotherapy for depressed preadolescents: An open-treatment trial. Early Intervention in Psychiatry, 2, 154–161.
Diler, R.S., Birmaher, B., Brent, D.A.et al. (2004). Phenomenology of panic disorder in youth. Depression and Anxiety, 20, 39–43.
Dubicka, B., Elvins, R., Roberts, C.et al. (2010). Combined treatment with cognitive-behavioural therapy in adolescent depression: Meta-analysis. British Journal of Psychiatry, 197, 433–440.
Emslie, G., Rush, J.A., Weinberg, W.A.et al. (1997). A double-blind, randomized placebo-controlled trial of fluoxetine in depressed children and adolescents with depression. Archives of General Psychiatry, 54, 1031–1037.
Emslie, G., Heiligenstein, J.H., Wagner, K.D.et al. (2002). Fluoxetine for acute treatment of depression in children and adolescents: A placebo-controlled, randomized clinical trial. Journal of the American Academy of Child and Adolescent Psychiatry, 41, 1205–1215.
Emslie, G.J., Ventura, D., Korotzer, A., and Tourkodimitris, S. (2009). Escitalopram in the treatment of adolescent depression: A randomized placebo-controlled multisite trial. Journal of the American Academy of Child and Adolescent Psychiatry, 48, 721–729.
Emslie, G.J., Findling, R.L., Yeung, P.P., Kunz, N.R., and Li, Y. (2007). Venlafaxine ER for the treatment of pediatric subjects with depression: Results of two placebo-controlled trials. Journal of the American Academy of Child and Adolescent Psychiatry, 46, 479–488.
Emslie, G.J., Kennard, B.D., Mayes, T.L.et al. (2008). Fluoxetine versus placebo in preventing relapse of major depression in children and adolescents. American Journal of Psychiatry, 165, 459–467.
Emslie, G.J., Kennard, B.D., Mayes, T.L.et al. (2012). Insomnia moderates outcome of serotonin-selective reuptake inhibitor treatment in depressed youth. Journal of Child and Adolescent Psychopharmacology, 22, 21–28.
Feeny, N.C., Silva, S.G., Reinecke, M.A.et al. (2009). An exploratory analysis of the impact of family functioning on treatment for depression in adolescents. Journal of Clinical Child and Adolescent Psychology, 38, 814–825.
Findling, R.L. (1996). Open-label treatment of comorbid depression and attentional disorders with co-administration of serotonin reuptake inhibitors and psychostimulants in children, adolescents, and adults: A case series. Journal of Child and Adolescent Psychopharmacology, 6, 165–175.
Findling, R.L., Nyilas, M., and Forbes, R.A.et al. (2009). Acute treatment of pediatric bipolar I disorder, manic or mixed episode, with aripiprazole: A randomized, double-blind, placebo-controlled study. Journal of Clinical Psychiatry, 70, 1441–1451.
Forbes, E.E. and Dahl, R.E. (2012). Research review: Altered reward function in adolescent depression: What, when and how?Journal of Child Psychology and Psychiatry, and Allied Disciplines, 53, 3–15.
Forbes, E.E., Bertocci, M.A., Gregory, A.M.et al. (2008). Objective sleep in pediatric anxiety disorders and major depressive disorder. Journal of the American Academy of Child and Adolescent Psychiatry, 47, 148–155.
Fristad, M.A., Verducci, J., Walters, K., and Young, M. (2009). Impact of multifamily psychoeducational psychotherapy in treating children aged 8 to 12 years with mood disorders. Archives of General Psychiatry, 66, 1013–1021.
Garber, J., Clarke, G., Weersing, R.et al. (2009). Prevention of depression in at-risk adolescents: A randomized controlled trial. Journal of the American Medical Association, 301, 2215–2224.
Geller, B., Fox, L.W., and Clark, K.A. (1994). Rate and predictors of prepubertal bipolarity during follow-up of 6- to 12-year-old depressed children. Journal of the American Academy of Child and Adolescent Psychiatry, 33, 461–468.
Geller, B., Tillman, R., Craney, J.L., and Bolhofner, K. (2004). Four-year prospective outcome and natural history of mania in children with a prepubertal and early adolescent bipolar disorder phenotype. Archives of General Psychiatry, 61, 459–467.
Geller, B., Zimerman, B., Williams, M.et al. (2002). DSM-IV mania symptoms in a prepubertal and early adolescent bipolar disorder phenotype compared to attention-deficit hyperactive and normal controls. Journal of Child Psychology and Psychiatry and Allied Disciplines, 12, 11–25.
Geller, B., Luby, J.L., Joshi, P.et al. (2012). A randomized controlled trial of risperidone, lithium, or divalproex sodium for initial treatment of bipolar I disorder, manic or mixed phase, in children and adolescents. Archives of General Psychiatry, 69, 515–528.
Georgiades, K., Lewinsohn, P.M., Monroe, S.M., and Seeley, J.R. (2006). Major depressive disorder in adolescence: The role of subthreshold symptoms. Journal of the American Academy of Child and Adolescent Psychiatry, 45, 936–944.
Gibbons, R.D., Brown, C.H., Hur, K., Davis, J.M., and Mann, J.J. (2012). Suicidal thoughts and behavior with antidepressant treatment: Reanalysis of the randomized placebo-controlled studies of fluoxetine and venlafaxine. Archives of General Psychiatry, 69, 580–587.
Gibbons, R.D., Brown, C.H., Hur, K.et al. (2007). Early evidence on the effects of regulators’ suicidality warnings on SSRI prescriptions and suicide in children and adolescents. American Journal of Psychiatry, 164, 1356–1363.
Goldstein, B.I., Shamseddeen, W., Spirito, A.et al. (2009). Substance use and the treatment of resistant depression in adolescents. Journal of the American Academy of Child and Adolescent Psychiatry, 48, 1182–1192.
Gonzalez-Tejera, G., Canino, G., Ramirez, R.et al. (2005). Examining minor and major depression in adolescents. Journal of Child Psychology and Psychiatry and Allied Disciplines, 46, 888–899.
Goodyer, I., Dubicka, B., Wilkinson, P.et al. (2007). Selective serotonin reuptake inhibitors (SSRIs) and routine specialist care with and without cognitive behaviour therapy in adolescents with major depression: Randomised controlled trial. British Medical Journal, 335, 106–107.
Gregory, A.M., Caspi, A., Moffitt, T.E., and Poulton, R. (2009). Sleep problems in childhood predict neuropsychological functioning in adolescence. Pediatrics, 123, 1171–1176.
Gunlicks-Stoessel, M., Mufson, L., Jekal, A., and Turner, J.B. (2010). The impact of perceived interpersonal functioning on treatment for adolescent depression: IPT-A versus treatment as usual in school-based health clinics. Journal of Consulting and Clinical Psychology, 78, 260–267.
Harrington, R., Rutter, M., Weissman, M.et al. (1997). Psychiatric disorders in the relatives of depressed probands. I. Comparison of prepubertal, adolescent and early adult onset cases. Journal of Affective Disorders, 42, 9–22.
Hazell, P., O’Connell, D., Heathcote, D., and Henry, D.A. (2002). Tricyclic drugs for depression in children and adolescents. Cochrane Database of Systematic Reviews, 2, CD002317.
Heiligenstein, J., Hoog, S.L., Wagner, K.D.et al. (2006). Fluoxetine 40–60 mg versus fluoxetine 20 mg in the treatment of children and adolescents with a less-than-complete response to nine-week treatment with fluoxetine 10–20 mg: A pilot study. Journal of Child and Adolescent Psychopharmacology, 16, 207–217.
Horowitz, J.L., Garber, J., Ciesla, J.A., Young, J.F., and Mufson, L. (2007). Prevention of depressive symptoms in adolescents: A randomized trial of cognitive-behavioral and interpersonal prevention programs. Journal of Consulting and Clinical Psychology, 75, 693–706.
Inoue, T., Abekawa, T., Nakagawa, S.et al. (2011). Long-term naturalistic follow-up of lithium augmentation: Relevance to bipolarity. Journal of Affective Disorders, 129, 64–67.
Kapur, S., Mieczkowski, T., and Mann, J. (1992). Antidepressant medications and the relative risk of suicide attempt and suicide. Journal of the American Medical Association, 268, 3441–3445.
Katz, L.Y., Kozyrskyj, A.L., Prior, H.J.et al. (2008). Effect of regulatory warnings on antidepressant prescription rates, use of health services and outcomes among children, adolescents and young adults. Canadian Medical Association Journal, 178, 1005–1011.
Kennard, B., Silva, S., Vitiello, B.et al. (2006). Remission and residual symptoms after short-term treatment in the Treatment of Adolescents with Depression Study (TADS). Journal of the American Academy of Child and Adolescent Psychiatry, 45, 1404–1411.
Kennard, B.D., Emslie, G.J., Mayes, T.L.et al. (2008). Cognitive-behavioral therapy to prevent relapse in pediatric response to pharmacotherapy for major depressive disorder. Journal of the American Academy of Child and Adolescent Psychiatry, 47, 1395–1404.
Kennard, B.D., Clarke, G.N., Weersing, V.R.et al. (2009). Effective components of TORDIA cognitive behavioral therapy for adolescent depression. Journal of Consulting and Clinical Psychology, 77, 1033–1041.
Koplewicz, H.S. (1997). It's Nobody's Fault: New Hope and Help for Difficult Children and Their Parents. New York, NY: Three Rivers Press.
Kovacs, M., Akiskal, H.S., Gatsonis, C., and Parrone, P.L. (1994). Childhood-onset dysthymic disorder: Clinical features and prospective naturalistic outcome. Archives of General Psychiatry, 51, 365–374.
Kovacs, M., Sherrill, J., George, C.J.et al. (2006). Contextual emotion-regulation therapy for childhood depression: Description and pilot testing of a new intervention. Journal of the American Academy of Child and Adolescent Psychiatry, 45, 892–903.
Kroll, L., Harrington, R., Jayson, D., and Fraser, J. (1996). Pilot study of continuation cognitive-behavioral therapy for major depression in adolescent psychiatric patients. Journal of the American Academy of Child and Adolescent Psychiatry, 35, 1156–1161.
Kupfer, D.J., Frank, E., Perel, J.M.et al. (1992). Five-year outcome for maintenance therapies in recurrent depression. Archives of General Psychiatry, 49, 769–773.
Larun, L., Nordheim, L.V., Ekeland, E., Hagen, K.B., and Heian, F. (2006). Exercise in prevention and treatment of anxiety and depression among children and young people. Cochrane Database of Systematic Reviews, 3, CD004691.
Leverich, G.S., Altshuler, L.L., Frye, M.A.et al. (2006). Risk of switch in mood polarity to hypomania or mania in patients with bipolar depression during acute and continuation trials of venlafaxine, sertraline, and bupropion as adjuncts to mood stabilizers. American Journal of Psychiatry, 163, 232–239.
Lewinsohn, P.M., Rohde, P., and Seeley, J.R. (1998a). Treatment of adolescent depression: Frequency of services and impact on functioning in young adulthood. Depression and Anxiety, 7, 47–52.
LewinsohnP.M., Rohde, P., and Seeley, J.R. (1998b). Major depressive disorder in older adolescents: Prevalence, risk factors, and clinical implications. Clinical Psychology Review, 18, 765–794.
Lewinsohn, P.M., Rohde, P., Seeley, J.R., and Klein, D.N. (1997). Axis II psychopathology as a function of Axis I disorders in childhood and adolescence. Journal of the American Academy of Child and Adolescent Psychiatry, 36, 1752–1759.
Lewis, C.C., Simons, A.D., Nguyen, L.J.et al. (2010). Impact of childhood trauma on treatment outcome in the Treatment for Adolescents with Depression Study (TADS). Journal of the American Academy of Child and Adolescent Psychiatry, 49, 132–140.
Libby, A.M., Orton, H.D., and Valuck, R.J. (2009). Persisting decline in depression treatment after FDA warnings. Archives of General Psychiatry, 66, 633–639.
Maalouf, F.T., Porta, G., Vitiello, B.et al. (2012). Do sub-syndromal manic symptoms influence outcome in treatment resistant depression in adolescents? A latent class analysis from the TORDIA study. Journal of Affective Disorders, 138, 86–95.
Mallinger, A.G., Frank, E., Thase, M.E.et al. (2009). Revisiting the effectiveness of standard antidepressants in bipolar disorder: Are monoamine oxidase inhibitors superior?Psychopharmacology Bulletin, 42, 64–74.
March, J., Silva, S., Petrycki, S.et al. (2004a). Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression: Treatment for Adolescent Depression Study (TADS) randomized controlled trial. Journal of the American Medical Association, 292, 807–820.
March, J.S., Foa, E., Gammon, P.et al. (2004b). Cognitive-behavior therapy, sertraline and their combination for children and adolescents with obsessive-compulsive disorder: The Pediatric OCD Treatment Study (POTS) randomized controlled trial. Journal of the American Medical Association, 292, 1969–1976.
March, J.S., Silva, S., Petrycki, S.et al. (2007). The Treatment for Adolescents with Depression Study (TADS): Long-term effectiveness and safety outcomes. Archives of General Psychiatry, 64, 1132–1144.
Martin, A., Young, C., Leckman, J.F.et al. (2004). Age effects on antidepressant-induced manic conversion. Archives of Pediatrics and Adolescent Medicine, 158, 773–780.
Mufson, L., Weissman, M.M., Moreau, D., and Garfinkel, R. (1999). Efficacy of interpersonal psychotherapy for depressed adolescents. Archives of General Psychiatry, 56, 573–579.
Mufson, L., Dorta, K.P., Wickramaratne, P.et al. (2004). A randomized effectiveness trial of interpersonal psychotherapy for depressed adolescents. Archives of General Psychiatry, 61, 577–584.
Nelson, J.C. and Papakostas, G.I. (2009). Atypical antipsychotic augmentation in major depressive disorder: A meta-analysis of placebo-controlled randomized trials. American Journal of Psychiatry, 166, 980–991.
Nemets, H., Nemets, B., Apter, A., Bracha, Z., and Belmaker, R.H. (2006). Omega-3 treatment of childhood depression: A controlled, double-blind pilot study. American Journal of Psychiatry, 163, 1098–1100.
Nihalani, N., Schwartz, T.L., Siddiqui, U.A., and Megna, J.L. (2011). Weight gain, obesity, and psychotropic prescribing. Journal of Obesity, Article ID 893629, doi: 10.1155/2011/893629 (Accessed March 2, 2012).
Nolen-Hoeksema, S. (2011). Emotion regulation and psychopathology: The role of gender. Annual Review of Clinical Psychology, 8, 161–187.
Owens, J.A., Rosen, C.L., Mindell, J.A., and Kirchner, H.L. (2010). Use of pharmacotherapy for insomnia in child psychiatry practice: A national survey. Sleep Medicine, 11, 692–700.
Pail, G., Huf, W., Pjrek, E.et al. (2011). Bright-light therapy in the treatment of mood disorders. Neuropsychobiology, 64, 152–162.
Quach, J., Hiscock, H., Ukoumunne, O.C., and Wake, M. (2011). A brief sleep intervention improves outcomes in the school entry year: A randomized controlled trial. Pediatrics, 128, 692–701.
Renaud, J., Brent, D.A., Baugher, M.et al. (1998). Rapid response to psychosocial treatment for adolescent depression: A two-year follow-up. Journal of the American Academy of Child and Adolescent Psychiatry, 37, 1184–1190.
Riggs, P.D., Mikulich-Gilbertson, S.K., Davies, R.D.et al. (2007). A randomized controlled trial of fluoxetine and cognitive behavioral therapy in adolescents with major depression, behavior problems, and substance use disorders. Archives of Pediatric and Adolescent Medicine, 161, 1026–1034.
Rohde, P., Seeley, J.R., Clarke, G.N., Kaufman, N.K., and Stice, E. (2006). Predicting time to recovery among depressed adolescents treated in two psychosocial group interventions. Journal of Consulting and Clinical Psychology, 74, 80–88.
Rossello, J. and Bernal, G. (1999). The efficacy of cognitive-behavioral and interpersonal treatments for depression in Puerto Rican adolescents. Journal of Consulting and Clinical Psychology, 67, 734–745.
Rossello, J., Bernal, G., and Rivera-Medina, C. (2008). Individual and group CBT and IPT for Puerto Rican adolescents with depressive symptoms. Cultural Diversity and Ethnic Minority Psychology, 14, 234–245.
Ryan, N.D., Puig-Antich, J., Ambrosini, P.et al. (1987). The clinical picture of major depression in children and adolescents. Archives of General Psychiatry, 44, 854–861.
Saeed, S.A., Antonacci, D.J., and Bloch, R.M. (2010). Exercise, yoga, and meditation for depressive and anxiety disorders. American Family Physician, 81, 981–986.
Sakolsky, D.J., Perel, J.M., Emslie, G.J.et al. (2011). Antidepressant exposure as a predictor of clinical outcomes in the Treatment of Resistant Depression in Adolescents (TORDIA) study. Journal of Clinical Psychopharmacology, 31, 92–97.
Sala, M., Vicentini, A., Brambilla, P.et al. (2005). QT interval prolongation related to psychoactive drug treatment: A comparison of monotherapy versus polytherapy. Annals of General Psychiatry, 4, 1.
Sallee, F.R., Vrindavanam, N.S., Deas-Nesmith, D., Carson, S.W., and Sethuraman, G. (1997). Pulse intravenous clomipramine for depressed adolescents: Double-blind, controlled trial. American Journal of Psychiatry, 154, 668–673.
Scharko, A.M. (2004). Selective serotonin reuptake inhibitor-induced sexual dysfunction in adolescents: A review. Journal of the American Academy of Child and Adolescent Psychiatry, 43, 1071–1079.
Shamseddeen, W., Clarke, G., Wagner, K.D.et al. (2011). Treatment-resistant depressed youth show a higher response rate if treatment ends during summer school break. Journal of the American Academy of Child and Adolescent Psychiatry, 50, 1140–1148.
Shamseddeen, W., Clarke, G., Keller, M.B.et al. (2012). Adjunctive sleep medications and depression outcome in the Treatment of SSRI Resistant Depression in Adolescents (TORDIA) study. Journal of Child and Adolescent Psychopharmacology, 22, 29–36.
Smits, J.A., Rosenfield, D., Mather, A.A.et al. (2010). Psychotropic medication use mediates the relationship between mood and anxiety disorders and obesity: Findings from a nationally representative sample. Journal of Psychiatric Research, 44, 1010–1016.
Stalets, M.M. and Luby, J.L. (2006). Preschool depression. Child and Adolescent Psychiatric Clinics of North America, 15, 899–917.
Stanley, B., Brown, G., Brent, D.et al. (2009). Cognitive Behavior Therapy for Suicide Prevention (CBT-SP): Treatment model, feasibility and acceptability. Journal of the American Academy of Child and Adolescent Psychiatry, 48, 1005–1013.
Stone, M., Laughren, T., Jones, M.L.et al. (2009). Risk of suicidality in clinical trials of antidepressants in adults: Analysis of proprietary data submitted to US Food and Drug Administration. British Medical Journal, 11, 339–342.
Strober, M. and Carlson, G. (1982). Bipolar illness in adolescents with major depression: Clinical, genetic, and psychopharmacologic predictors in a three- to four-year prospective follow-up investigation. Archives of General Psychiatry, 39, 549–555.
Verdel, B.M., Souverein, P.C., Egberts, T.C.et al. (2010). Use of antidepressant drugs and risk of osteoporotic and non-osteoporotic fractures. Bone, 47, 604–609.
Vitiello, B., Silva, S.G., RohdeP.et al. (2009). Suicidal events in the Treatment of Adolescents with Depression Study (TADS). Journal of Clinical Psychiatry, 70, 741–747.
Vitiello, B., Emslie, G., Clarke, G.et al. (2011). Long-term outcome of adolescent depression initially resistant to selective serotonin reuptake inhibitor treatment: A follow-up study of the TORDIA sample. Journal of Clinical Psychiatry, 72, 388–396.
Wachtel, L.E., Dhossche, D.M., and Kellner, C.H. (2011). When is electroconvulsive therapy appropriate for children and adolescents?Medical Hypotheses, 76, 395–399.
Wagner, K.D., Jonas, J., Findling, R.L., Ventura, D., and Saikali, K. (2006). A double-blind randomized, placebo-controlled trial of escitalopram in the treatment of pediatric depression. Journal of the American Academy of Child and Adolescent Psychiatry, 45, 280–288.
Walkup, J.T., Albano, A.M., Piacentini, J.et al. (2008). Cognitive behavioral therapy, sertraline, or a combination in childhood anxiety. New England Journal of Medicine, 359, 2753–2766.
Walter, G. and Rey, J.M. (2003). Has the practice and outcome of ECT in adolescents changed? Findings from a whole-population study. Journal of ECT, 19, 84–87.
Weinrieb, R.M., Auriacombe, M., Lynch, K.G., and Lewis, J.D. (2005). Selective serotonin re-uptake inhibitors and the risk of bleeding. Expert Opinion on Drug Safety, 4, 337–344.
Weissman, M., Wolk, S., Goldstein, R.et al. (1999a). Depressed adolescents grown up. Journal of the American Medical Association, 281, 1707–1713.
Weissman, M.M., Wolk, S., Wickramaratne, P.et al. (1999b). Children with prepubertal onset major depressive disorder and anxiety grown up. Archives of General Psychiatry, 56, 794–801.
Weissman, M.M., Wickramaratne, P., Nomura, Y.et al. (2005). Families at high and low risk for depression: A 3-generation study. Archives of General Psychiatry, 62, 29–36.
Weisz, J.R., McCarty, C.A., and Valeri, S.M. (2006). Effects of psychotherapy for depression in children and adolescents: A meta-analysis. Psychological Bulletin, 132, 132–149.
Weisz, J.R., Thurber, C.A., Sweeney, L., Proffitt, V.D., and LeGagnoux, G.L. (1997). Brief treatment of mild-to-moderate child depression using primary and secondary control enhancement training. Journal of Consulting and Clinical Psychology, 65, 703–707.
White, N., Litovitz, T., and Clancy, C. (2008). Suicidal antidepressant overdoses: A comparative analysis by antidepressant type. Journal of Medical Toxicology, 4, 238–250.
Wilkinson, P., Kelvin, R., Roberts, C., Dubicka, B., and Goodyer, I. (2011). Clinical and psychosocial predictors of suicide attempts and nonsuicidal self-injury in the Adolescent Depression Antidepressants and Psychotherapy Trial (ADAPT). American Journal of Psychiatry, 168, 495–501.
Wood, A., Harrington, R., and Moore, A. (1996). Controlled trial of a brief cognitive-behavioural intervention in adolescent patients with depressive disorders. Journal of Child Psychology and Psychiatry, 37, 737–746.
Young, J.F., Gallop, R., and Mufson, L. (2009). Mother-child conflict and its moderating effects on depression outcomes in a preventive intervention for adolescent depression. Journal of Clinical Child and Adolescent Psychology, 38, 696–704.